182 related articles for article (PubMed ID: 22913215)
1. Effect of 3-month L-arginine supplementation on insulin resistance and tumor necrosis factor activity in patients with visceral obesity.
Bogdanski P; Suliburska J; Grabanska K; Musialik K; Cieslewicz A; Skoluda A; Jablecka A
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):816-23. PubMed ID: 22913215
[TBL] [Abstract][Full Text] [Related]
2. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
[TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].
Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults.
Ho RC; Davy KP; Hickey MS; Melby CL
Cytokine; 2005 Apr; 30(1):14-21. PubMed ID: 15784408
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes.
Szulińska M; Piorunek T; Suliburska J; Pupek-Musialik D; Kupsz J; Drzymala-Czyż S; Bogdański P
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1916-22. PubMed ID: 23877857
[TBL] [Abstract][Full Text] [Related]
6. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
González-Clemente JM; Mauricio D; Richart C; Broch M; Caixàs A; Megia A; Giménez-Palop O; Simón I; Martínez-Riquelme A; Giménez-Pérez G; Vendrell J
Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
[TBL] [Abstract][Full Text] [Related]
7. Relationship between serum resistin concentration and proinflammatory cytokines in obese women with impaired and normal glucose tolerance.
Janowska J; Zahorska-Markiewicz B; Olszanecka-Glinianowicz M
Metabolism; 2006 Nov; 55(11):1495-9. PubMed ID: 17046552
[TBL] [Abstract][Full Text] [Related]
8. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
9. Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity.
Dalziel B; Gosby AK; Richman RM; Bryson JM; Caterson ID
Obes Res; 2002 May; 10(5):401-7. PubMed ID: 12006640
[TBL] [Abstract][Full Text] [Related]
10. [TNF-alpha and carbohydrate and lipid parameters in overweight and obese children].
Goral J
Ann Acad Med Stetin; 2008; 54(2):14-21. PubMed ID: 19374226
[TBL] [Abstract][Full Text] [Related]
11. Three measures of tumor necrosis factor alpha activity and insulin resistance in nonobese Japanese type 2 diabetic patients.
Ohya M; Taniguchi A; Fukushima M; Nakai Y; Kawasaki Y; Nagasaka S; Kuroe A; Taki Y; Yoshii S; Hosokawa M; Inagaki N; Seino Y
Metabolism; 2005 Oct; 54(10):1297-301. PubMed ID: 16154427
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
Lucotti P; Setola E; Monti LD; Galluccio E; Costa S; Sandoli EP; Fermo I; Rabaiotti G; Gatti R; Piatti P
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
[TBL] [Abstract][Full Text] [Related]
13. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance.
Carneiro G; Togeiro SM; Ribeiro-Filho FF; Truksinas E; Ribeiro AB; Zanella MT; Tufik S
Metab Syndr Relat Disord; 2009 Dec; 7(6):537-42. PubMed ID: 19558268
[TBL] [Abstract][Full Text] [Related]
14. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
15. Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients.
Ersoy C; Imamoğlu S; Budak F; Tuncel E; Ertürk E; Oral B
Indian J Med Res; 2004 Nov; 120(5):481-8. PubMed ID: 15591634
[TBL] [Abstract][Full Text] [Related]
16. The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation.
Gençtoy G; Kahraman S; Arici M; Altun B; Erdem Y; Bakkaloğlu M; Yasavul U; Turgan C
Transplant Proc; 2006 Mar; 38(2):521-8. PubMed ID: 16549165
[TBL] [Abstract][Full Text] [Related]
17. Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus.
Fernandez-Real JM; Lainez B; Vendrell J; Rigla M; Castro A; Peñarroja G; Broch M; Pérez A; Richart C; Engel P; Ricart W
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E952-9. PubMed ID: 11882518
[TBL] [Abstract][Full Text] [Related]
18. The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance.
Casano-Sancho P; López-Bermejo A; Fernández-Real JM; Monrós E; Valls C; Rodríguez-González FX; Ricart W; Ibáñez L
Clin Endocrinol (Oxf); 2006 Feb; 64(2):129-35. PubMed ID: 16430709
[TBL] [Abstract][Full Text] [Related]
19. The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
Chen H; Ren A; Hu S; Mo W; Xin X; Jia W
Diabetes Res Clin Pract; 2007 Mar; 75(3):327-32. PubMed ID: 16930761
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
